Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc.verified

KALA

Price:

$6.24

Market Cap:

$28.77M

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-07-20

Stock Exchange

NASDAQ

Ticker

KALA

The ROE as of December 2024 (TTM) for Kala Pharmaceuticals, Inc. (KALA) is -448.61%

According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -448.61%. This represents a change of 264.32% compared to the average of -123.13% of the last 4 quarters.

Kala Pharmaceuticals, Inc. (KALA) Historical ROE (quarterly & annually)

How has KALA ROE performed in the past?

The mean historical ROE of Kala Pharmaceuticals, Inc. over the last ten years is -256.23%. The current -448.61% ROE has changed 75.08% with respect to the historical average. Over the past ten years (40 quarters), KALA's ROE was at its highest in in the March 2022 quarter at 624.60%. The ROE was at its lowest in in the September 2022 quarter at -3003.41%.

Quarterly (TTM)
Annual

Average

-256.23%

Median

-87.79%

Minimum

-906.31%

Maximum

37.79%

Kala Pharmaceuticals, Inc. (KALA) ROE by Quarter and Year

Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 47.75%

Maximum Annual ROE = 37.79%

Minimum Annual Increase = -224.55%

Minimum Annual ROE = -906.31%

Quarterly (TTM)
Annual
YearROEChange
2023-562.35%47.75%
2022-1.18%-99.87%
2021-906.31%709.13%
2020-112.01%-67.39%
2019-343.47%440.32%
2018-63.57%35.05%
2017-47.07%-224.55%
201637.79%28.37%
201529.44%-104.96%
2014-593.53%-88.75%

Kala Pharmaceuticals, Inc. (KALA) Average ROE

How has KALA ROE performed in the past?

The current ROE of Kala Pharmaceuticals, Inc. (KALA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-489.95%

5-year avg

-385.06%

10-year avg

-256.23%

Kala Pharmaceuticals, Inc. (KALA) ROE vs. Peers

How is KALA’s ROE compared to its peers?

Kala Pharmaceuticals, Inc.’s ROE is greater than Mallinckrodt plc (-74.45%), less than Lifecore Biomedical, Inc. (17.23%), greater than Lucy Scientific Discovery Inc. (-296.96%), greater than Alimera Sciences, Inc. (-33.70%), less than Adamis Pharmaceuticals Corporation (0.33%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Journey Medical Corporation (-132.10%), greater than Akanda Corp. (-753.35%), less than Organogenesis Holdings Inc. (-2.69%), greater than Biofrontera Inc. (-324.62%), less than Guardion Health Sciences, Inc. (77.24%), greater than China Pharma Holdings, Inc. (-63.93%), less than Alkermes plc (26.49%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Intra-Cellular Therapies, Inc. (-9.93%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Dynavax Technologies Corporation (3.19%),

Build a custom stock screener for Kala Pharmaceuticals, Inc. (KALA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kala Pharmaceuticals, Inc. (KALA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Kala Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Kala Pharmaceuticals, Inc. (KALA)?

What is the highest ROE for Kala Pharmaceuticals, Inc. (KALA)?

What is the 3-year average ROE for Kala Pharmaceuticals, Inc. (KALA)?

What is the 5-year average ROE for Kala Pharmaceuticals, Inc. (KALA)?

How does the current ROE for Kala Pharmaceuticals, Inc. (KALA) compare to its historical average?